148 related articles for article (PubMed ID: 36352147)
21. Construction of an immune-related gene signature for prediction of prognosis in patients with cervical cancer.
Mei J; Xing Y; Lv J; Gu D; Pan J; Zhang Y; Liu J
Int Immunopharmacol; 2020 Nov; 88():106882. PubMed ID: 32799114
[TBL] [Abstract][Full Text] [Related]
22. CD177+ neutrophils suppress epithelial cell tumourigenesis in colitis-associated cancer and predict good prognosis in colorectal cancer.
Zhou G; Peng K; Song Y; Yang W; Shu W; Yu T; Yu L; Lin M; Wei Q; Chen C; Yin L; Cong Y; Liu Z
Carcinogenesis; 2018 Feb; 39(2):272-282. PubMed ID: 29228136
[TBL] [Abstract][Full Text] [Related]
23. Neutrophil transmigration mediated by the neutrophil-specific antigen CD177 is influenced by the endothelial S536N dimorphism of platelet endothelial cell adhesion molecule-1.
Bayat B; Werth S; Sachs UJ; Newman DK; Newman PJ; Santoso S
J Immunol; 2010 Apr; 184(7):3889-96. PubMed ID: 20194726
[TBL] [Abstract][Full Text] [Related]
24. The neutrophil subset defined by CD177 expression is preferentially recruited to gingival crevicular fluid in periodontitis.
Dahlstrand Rudin A; Amirbeagi F; Davidsson L; Khamzeh A; Thorbert Mros S; Thulin P; Welin A; Björkman L; Christenson K; Bylund J
J Leukoc Biol; 2021 Feb; 109(2):349-362. PubMed ID: 32531826
[TBL] [Abstract][Full Text] [Related]
25. Gene silencing and a novel monoallelic expression pattern in distinct CD177 neutrophil subsets.
Eulenberg-Gustavus C; Bähring S; Maass PG; Luft FC; Kettritz R
J Exp Med; 2017 Jul; 214(7):2089-2101. PubMed ID: 28559244
[TBL] [Abstract][Full Text] [Related]
26. Expression of the HOXA gene family and its relationship to prognosis and immune infiltrates in cervical cancer.
Ge F; Tie W; Zhang J; Zhu Y; Fan Y
J Clin Lab Anal; 2021 Nov; 35(11):e24015. PubMed ID: 34606634
[TBL] [Abstract][Full Text] [Related]
27. The nonconservative CD177 single-nucleotide polymorphism c.1291G>A is a genetic determinant for human neutrophil antigen-2 atypical/low expression and deficiency.
Wu J; Li Y; Schuller RM; Li L; Litmeyer AS; Bein G; Sachs UJ; Bayat B
Transfusion; 2019 May; 59(5):1836-1842. PubMed ID: 30828823
[TBL] [Abstract][Full Text] [Related]
28. Characterization of a novel mouse model with genetic deletion of CD177.
Xie Q; Klesney-Tait J; Keck K; Parlet C; Borcherding N; Kolb R; Li W; Tygrett L; Waldschmidt T; Olivier A; Chen S; Liu GH; Li X; Zhang W
Protein Cell; 2015 Feb; 6(2):117-26. PubMed ID: 25359465
[TBL] [Abstract][Full Text] [Related]
29. The
Traum A; Jehle S; Waxmann Y; Litmeyer AS; Berghöfer H; Bein G; Dammann R; Perniss A; Burg-Roderfeld M; Sachs UJ; Bayat B
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474126
[TBL] [Abstract][Full Text] [Related]
30. Multidimension Analysis of the Prognostic Value, Immune Regulatory Function, and ceRNA Network of LY6E in Individuals with Colorectal Cancer.
Li T; Liu W; Wang C; Wang M; Hui W; Lu J; Gao F
J Immunol Res; 2022; 2022():5164265. PubMed ID: 35310607
[TBL] [Abstract][Full Text] [Related]
31. GJA1 Expression and Its Prognostic Value in Cervical Cancer.
Meng S; Fan X; Zhang J; An R; Li S
Biomed Res Int; 2020; 2020():8827920. PubMed ID: 33299882
[TBL] [Abstract][Full Text] [Related]
32. Systematic Construction and Validation of a Novel Ferroptosis-Related Gene Model for Predicting Prognosis in Cervical Cancer.
Qin W; He C; Jiang D; Gao Y; Chen Y; Su M; Yang Y; Yang Z; Cai H; Wang H
J Immunol Res; 2022; 2022():2148215. PubMed ID: 35935576
[TBL] [Abstract][Full Text] [Related]
33. Identification of
Wang Y; Fang Y; Zhao F; Gu J; Lv X; Xu R; Zhang B; Fang Z; Li Y
Front Genet; 2022; 13():810292. PubMed ID: 35368661
[TBL] [Abstract][Full Text] [Related]
34. Utility of a metabolic-associated nomogram to predict the recurrence-free survival of stage I cervical cancer.
Zhang Y; Lu H; Zhang J; Wang S
Future Oncol; 2021 Apr; 17(11):1325-1337. PubMed ID: 33631974
[TBL] [Abstract][Full Text] [Related]
35. A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer.
Peng Y; Wang H; Huang Q; Wu J; Zhang M
J Ovarian Res; 2022 Jan; 15(1):8. PubMed ID: 35031063
[TBL] [Abstract][Full Text] [Related]
36. The pan-cancer analysis identified DIAPH3 as a diagnostic biomarker of clinical cancer.
Chen X; Xie L; Qiao K; Zhu X; Ren J; Tan Y
Aging (Albany NY); 2023 Jan; 15(3):689-704. PubMed ID: 36750200
[TBL] [Abstract][Full Text] [Related]
37. Construction of Immune-Associated Nomogram for Predicting the Recurrence Survival Risk of Stage I Cervical Cancer.
Wang Y; Zhang L; Wang B; Cheng Y
Biomed Res Int; 2021; 2021():6699131. PubMed ID: 34337046
[TBL] [Abstract][Full Text] [Related]
38. PLOD2 Is a Potent Prognostic Marker and Associates with Immune Infiltration in Cervical Cancer.
Li G; Wang X; Liu G
Biomed Res Int; 2021; 2021():5512340. PubMed ID: 34258263
[TBL] [Abstract][Full Text] [Related]
39. Identification of prognosis-related genes in the cervical cancer immune microenvironment.
Yang L; Yang Y; Meng M; Wang W; He S; Zhao Y; Gao H; Tang W; Liu S; Lin Z; Li L; Hou Z
Gene; 2021 Jan; 766():145119. PubMed ID: 32946928
[TBL] [Abstract][Full Text] [Related]
40. CD177-mediated nanoparticle targeting of human and mouse neutrophils.
Miettinen HM; Gripentrog JM; Lord CI; Nagy JO
PLoS One; 2018; 13(7):e0200444. PubMed ID: 29990379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
